Biomarker-Guided Anti-inflammatory Therapies: From Promise to Reality Check

Michael Berk^{1

2}, Adam J Walker¹, Andrew A Nierenberg³

Affiliations

¹ Deakin University, IMPACT Strategic Research Centre, Geelong, Victoria, Australia.
² Orygen, The National Centre of Excellence in Youth Mental Health, Department of Psychiatry, the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia.
³ Massachusetts General Hospital and Harvard Medical School, Boston.

Editorial

Michael Berk et al. JAMA Psychiatry. 2019.

. 2019 Aug 1;76(8):779-780.

doi: 10.1001/jamapsychiatry.2019.0673.

Michael Berk^{1

2}, Adam J Walker¹, Andrew A Nierenberg³

¹ Deakin University, IMPACT Strategic Research Centre, Geelong, Victoria, Australia.
² Orygen, The National Centre of Excellence in Youth Mental Health, Department of Psychiatry, the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia.
³ Massachusetts General Hospital and Harvard Medical School, Boston.

No abstract available

Comment on

Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial.
McIntyre RS, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, Rosenblat JD, Brietzke E, Soczynska JK, Cosgrove VE, Miller S, Fischer EG, Kramer NE, Dunlap K, Suppes T, Mansur RB. McIntyre RS, et al. JAMA Psychiatry. 2019 Aug 1;76(8):783-790. doi: 10.1001/jamapsychiatry.2019.0779. JAMA Psychiatry. 2019. PMID: 31066887 Free PMC article. Clinical Trial.